Isotechnika Pharma Inc IPHAF

RE: Broski

[stockman6]

Broski was employed by ISA for only 5 months. Here is what was said in November when he was hired: "Dr. Yatscoff says: “Dr. Broski will be responsible for dealing with the FDA, Health Canada and other government regulatory agencies.” " Obviously he wasn't panning out. I doubt we will here more detail. It's possible that his position also became less important to ISA now that Roche is on board. I'm sure that Roche Canada has numerous people that already have a good relationship with FDA, Health Canada, etc. They are likely much better prepared and experienced in getting the necessary regulatory approvals expedited than Broski was. I don't believe you should expect any bad news or delays on the renal trial front. On the contrary, I'm expecting enrollment to accelerate with Roche "helping" to increase the profile of the renal trials.